Identification of a Mimotope Peptide Bound to the SARS-CoV Spike Protein Specific Monoclonal Antibody 2C5 with Phage-displayed Peptide Library

Chinese Journal of Biotechnology

Volumn 22, Issue 5, 2006, Pages 701-706

  HUA, Rong Hong ^a   WU, Dong Lai ^a   TONG, Guang Zhi ^a   WANG, Yun Feng ^a   TIAN, Zhi Jun ^a   ZHOU, Yan Jun ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

mimotope; phage displayed peptide library; severe acute respiratory syndrome coronavirus virus (SARS CoV); spike protein

Indexed keywords

CORONAVIRUS; SARS CORONAVIRUS;

EPITOPE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MOLECULAR GENETICS; SARS CORONAVIRUS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; SARS VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 33749425959     PISSN: 18722075     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1872-2075(06)60051-4     Document Type: Article

References (24)

1. Babcock G., Esshaki D., Thomas Jr. W., et al. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78 9 (2004) 4552-4560
2. Wong S., Li W., Moore M., et al. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279 5 (2004) 3197-3201
3. Gallagher T., and Buchmeier M. Coronavirus spike proteins ein viral entry and pathogenesis. Virology 279 2 (2001) 371-374
4. Hofmann H., and Pohlmann S. Cellular entry of the SARS coronavirus. Trends Microbiol 12 10 (2004) 466-472
5. Bisht H., Roberts A., Vogel L., et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. PNAS 101 17 (2004) 6641-6646
6. Buchholz U., Bukreyev A., Yang L., et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. PNAS 101 26 (2004) 9804-9809
7. Bukreyev A., Lamirande E., Buchholz U., et al. Mucosal immunization of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363 9427 (2004) 2122-2127
8. He Y., Zhou Y., Liu S., et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 324 2 (2004) 773-781
9. Berry J., Jones S., Drebot M., et al. Development and characterization of neutralizing monoclonal antibody to the SARS-coronavirus. J Virol Methods 120 1 (2004) 87-96
10. Greenough T., Babcock G., Roberts A., et al. Development and characterization of a severe acute respiratory syndrome- associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis 191 4 (2005) 507-514
11. Zhou Y., Hua R., Wang Y., et al. Development of monoclonal antibodies against SARS-CoV and identification of antigenic epitopes. Chinese Journal of Biotechnology 21 2 (2005) 211-215
12. Gubbins M., Plummer F., Yuan X., et al. Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus. Mol Immunol 42 1 (2005) 125-136
13. Hua R., Tong G., Wang Y., et al. Expression and antigenic epitopes mapping of receptor binding domain on the spike protein of severe acute respiratory syndrome coronavirus. Prog Biochem Biophys 32 11 (2005) 1030-1037
14. Hua R., Wang Y., Bu Z., et al. Identification and epitope mapping of an immunodominant region on S1 domain of SARS-CoV spike protein. DNA and Cell Biology 24 8 (2005) 503-509
15. Hua R., Zhou Y., Wang Y., et al. Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem Biophys Res Commun 319 3 (2004) 929-935
16. Zhang H., Wang G., Li J., et al. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome xoronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol 78 13 (2004) 6938-6945
17. He Y., Lu H., Siddiqui P., et al. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 174 8 (2005) 4908-4915
18. Smith G. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 4705 (1985) 1315-1317
19. Parmley S., and Smith G. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73 2 (1988) 305-318
20. Hou L., Du G., Tong Y., et al. Identification of B cell epitopes of hepatitis C virus RNA dependent RNA polymerase. J Virol Methods 104 1 (2002) 1-8
21. Dell'Orco M., Saldarelli P., Minafra A., et al. Epitope mapping of Grapevine virus A capsid protein. Arch Virol 147 3 (2002) 627-634
22. Cerino A., Meola A., Segagni L., et al. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J Immunol 167 7 (2001) 3878-3886
23. He Y., Zhu Q., Liu S., et al. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 334 1 (2005) 74-82
24. Chou T., Wang S., Sakhatskyy P., et al. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 334 1 (2005) 134-143